Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-28

Clinical Trial Update: A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing vinflunine plus gemcitabine to paclitaxel plus gemcitabine in advanced breast cancer was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemcitabine (Gemcitabine)
  • PACLITAXEL (PACLITAXEL)
  • Vinflunine (vinflunine)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Advanced Breast Cancer | Phase 3 | Status: TERMINATED | Results posted: 2019-08-28